Whether investigating fat cells, immunotherapy or use of the CRISPR - Cas 9 gene - editing tool, which a federal panel recently approved for a select number of patients suffering from three
types of
cancers, including
multiple myeloma, approaches beyond attacking
cancer cells are needed in the
fight against many
cancers.